Calidi Biotherapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLDI research report →
About the company
Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approach centers on utilizing powerful, allogeneic (donor-derived) stem cells as specialized carriers for anti-tumor agents.
- CEO
- Eric E. Poma
- IPO
- 2021
- Employees
- 28
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $1.10M
- P/E
- -0.03
- P/S
- 0.00
- P/B
- 0.31
- EV/EBITDA
- 0.19
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -438.03%
- ROIC
- -266.77%
- Revenue
- $0 · 0.00%
- Net Income
- $-19,906,000 · 10.10%
- EPS
- $-5.95 · 83.33%
- Op Income
- $-20,240,000
- FCF YoY
- -8.64%
- 52W High
- $19.20
- 52W Low
- $0.12
- 50D MA
- $0.19
- 200D MA
- $0.85
- Beta
- 1.30
- Avg Volume
- 6.03M
Get TickerSpark's AI analysis on CLDI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 17, 26 | Sanders Corazon (Corsee) D. | other | 0 |
| Dec 12, 25 | Camaisa Allan | sell | 850 |
| Sep 3, 25 | Poma Eric E | other | 10,000 |
| Sep 3, 25 | Fernandez Santidrian Antonio | other | 35,000 |
| Sep 3, 25 | Jackson Andrew C. | other | 30,000 |
| Aug 20, 25 | Lincoln Alternative Strategies LLC | other | 0 |
| Aug 21, 25 | Schoeneck James A | buy | 75,000 |
| Aug 21, 25 | Schoeneck James A | buy | 75,000 |
| Aug 21, 25 | Poma Eric E | buy | 25,000 |
| Aug 21, 25 | Poma Eric E | buy | 25,000 |
Our CLDI coverage
Recent articles, reports, and earnings notes.
No research on CLDI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CLDI report →Similar companies
Peers in the same neighborhood.